These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


558 related items for PubMed ID: 23464866

  • 1. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY, Park MJ, Park S, Lee ES.
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [Abstract] [Full Text] [Related]

  • 4. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ, Park JS, Kang MI, Lee SK, Park YB, Lee SW.
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [Abstract] [Full Text] [Related]

  • 5. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease.
    Hamzaoui K, Houman H, Ben Dhifallah I, Kamoun M, Hamzaoui A.
    Clin Exp Rheumatol; 2008 Dec; 26(4 Suppl 50):S64-71. PubMed ID: 19026118
    [Abstract] [Full Text] [Related]

  • 6. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
    Liu X, Wang C, Ye Z, Kijlstra A, Yang P.
    Invest Ophthalmol Vis Sci; 2013 Sep 05; 54(9):6012-7. PubMed ID: 23908180
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
    Çerçi P, Altıner S, İnal A, Köse K, Keskin G, Ölmez Ü.
    Acta Clin Belg; 2017 Dec 05; 72(6):434-438. PubMed ID: 28412856
    [Abstract] [Full Text] [Related]

  • 9. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
    Shimizu J, Izumi T, Arimitsu N, Fujiwara N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Takai K, Suzuki N.
    Clin Exp Rheumatol; 2012 Dec 05; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H, Xia LP, Lu J.
    Scand J Rheumatol; 2013 Dec 05; 42(1):48-51. PubMed ID: 23101722
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K, Ben Dhifallah I, Karray E, Sassi FH, Hamzaoui A.
    Clin Exp Rheumatol; 2010 Dec 05; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C, Er H, Türköz Y, Cekmen M.
    Mediators Inflamm; 2002 Apr 05; 11(2):87-93. PubMed ID: 12061429
    [Abstract] [Full Text] [Related]

  • 14. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
    Perazzio SF, Soeiro-Pereira PV, de Souza AW, Condino-Neto A, Andrade LE.
    Clin Exp Rheumatol; 2015 Apr 05; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B, Xie C, Lin X, Su SB.
    Cell Immunol; 2014 Jul 05; 290(1):116-9. PubMed ID: 24973639
    [Abstract] [Full Text] [Related]

  • 16. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
    Zou J, Ji DN, Shen Y, Guan JL, Zheng SB.
    Ann Clin Lab Sci; 2016 Dec 05; 46(6):675-679. PubMed ID: 27993883
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W, Bouali E, Berraïes A, Dhifallh IB, Hamdi B, Hamzaoui K, Hamzaoui A.
    Immunol Lett; 2017 Oct 05; 190():177-184. PubMed ID: 28811236
    [Abstract] [Full Text] [Related]

  • 19. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K, Bouali E, Ghorbel I, Khanfir M, Houman H, Hamzaoui A.
    Med Sci Monit; 2011 Apr 05; 17(4):CR227-34. PubMed ID: 21455110
    [Abstract] [Full Text] [Related]

  • 20. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Jul 05; 49(7):3058-64. PubMed ID: 18579762
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.